The news cycle for Seattle biotech is revving up again, after everybody but the lab mice took a rest during the holidays. We found some predictable doom and gloom (the shutdown of Northstar Neuroscience) to go with a more upbeat exclusive about a cancer drugmaker emerging in town (Qwell Pharmaceuticals.) Here are the past couple … Continue reading “Zymo Boss Sees Immunex Parallel, Arch Startup Bags $7M, Northstar Folds, & More Seattle-Area Life Sciences News”
Anaphore Raises $25 Million in Venture Funding
Anaphore, a La Jolla biotech near our Xconomy San Diego office, says it has raised $25 million in a Series A round led by 5AM Ventures, Versant Ventures, and Apposite Capital. Headed by founder and CEO Katherine Bowdish, Anaphore is developing a new class of protein therapeutics the company calls Atrimers. Anaphore says it’s novel drug … Continue reading “Anaphore Raises $25 Million in Venture Funding”
Play Hard Sports, Inc. Garners $5,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=68e39efb-6d8e-4b9d-abaf-29bf131f5180&Preview=1 Date 1/8/2009 Company Name Play Hard Sports, Inc. Mailing Address 16 Chestnut Street Foxboro, MA 02035 Company Description Play Hard Sports, Inc. (Play Hard) is the first casual sports network in North America focused exclusively on developing, publishing and distributing exceptional sports games and entertainment across the Internet. Play Hard is … Continue reading “Play Hard Sports, Inc. Garners $5,000,000 Series A Financing”
Anaphore, Inc. Secures $25,000,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aaa8b988-5145-429c-b58f-06da897af447&Preview=1 Date 1/8/2009 Company Name Anaphore, Inc. Mailing Address Undisclosed San Diego, CA 92120 Company Description Anaphore was created through the acquisition of Borean Pharma ApS, a Danish biotechnology company with both a product portfolio and technology platforms for creating improved protein therapeutics. The Danish firm spent six years establishing the technologies … Continue reading “Anaphore, Inc. Secures $25,000,000 Series A Funding”
CFX Battery Lands $11,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=41cb81f3-0104-482b-bd57-0db19f41a34a&Preview=1 Date 1/8/2009 Company Name CFX Battery Mailing Address 1300 W. Optical Drive Azusa, CA 91702 Company Description CFX Battery’s objective is to provide unique, cost-effective, and state-of-the-art energy storage solutions for a wide variety of applications. Website http://www.cfxbattery.com Transaction Type Venture Equity Transaction Amount $11,000,000 Transaction Round Series A Proceeds Purposes … Continue reading “CFX Battery Lands $11,000,000 Series A Funding Round”
Satori Pharmaceuticals, Inc. Garners $22,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a3eda3b6-367b-49f5-bff6-665723e398bd&Preview=1 Date 1/8/2009 Company Name Satori Pharmaceuticals, Inc. Mailing Address 222 Berkeley Street Boston, MA 02116 Company Description Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative disorders. Website http://www.satoripharma.com Transaction Type Venture Equity Transaction Amount $22,000,000 … Continue reading “Satori Pharmaceuticals, Inc. Garners $22,000,000 Series B Financing Round”
JibJab Media Inc. Secures $7,500,000 Series C Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=584107e6-d02e-4907-968b-2051587cccf1&Preview=1 Date 1/8/2009 Company Name JibJab Media Inc. Mailing Address P.O. BOX 5356 Santa Monica, CA 90404 Company Description JibJab Media Inc. is an online comedy network that has been pioneering digital entertainment production and distribution since 1999. Website http://www.jibjab.com Transaction Type Venture Equity Transaction Amount $7,500,000 Transaction Round Series C Proceeds … Continue reading “JibJab Media Inc. Secures $7,500,000 Series C Round”
Superprotonic Garners $8,000,000 Series C Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a81b2bca-cba0-4aac-b9c3-62344b0d0908&Preview=1 Date 1/8/2009 Company Name Superprotonic Mailing Address 530 S. Lake Ave. Pasadena, CA 91101 Company Description Superprotonic is an energy technology company established to market and commercialize the innovative solid acid fuel cell (SAFC) technology developed and patented by the company’s founders at the California Institute of Technology. Solid acid fuel … Continue reading “Superprotonic Garners $8,000,000 Series C Round”
Digital Entertainment Corporation of America Garners $10,000,000 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8a8d582d-bb23-4e25-9388-d16bb0b321da&Preview=1 Date 1/8/2009 Company Name Digital Entertainment Corporation of America Mailing Address Undisclosed Santa Monica, CA 90401 Company Description The company operates a digital entertainment studio. Website Undisclosed Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Series B Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Rustic Canyon … Continue reading “Digital Entertainment Corporation of America Garners $10,000,000 Series B Funding Round”
Concentric Medical Secures $15,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aa01b739-b6aa-4d51-a483-5e0b85242aac&Preview=1 Date 1/8/2009 Company Name Concentric Medical Mailing Address 301 East Evelyn Avenue Mountain View, CA 94041 Company Description Concentric Medical, Inc., headquartered in Mountain View, CA, is a medical device company focused on the design, development and commercialization of products for restoring blood flow in patients who are experiencing an ischemic … Continue reading “Concentric Medical Secures $15,000,000 New Round”
Aptus Endosystems Obtains $30,000,000 Series C Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dcdfb754-04f5-4ad3-89f5-5fd299a2cd7b&Preview=1 Date 1/8/2009 Company Name Aptus Endosystems Mailing Address 777 N. Pastoria Avenue Sunnyvale, CA 94085-2918 Company Description Aptus Endosystems is a privately held, well-funded, emerging medical device company that is engaged in the development of next generation minimally invasive endograft devices, delivery systems and fixation technology for the treatment of Abdominal … Continue reading “Aptus Endosystems Obtains $30,000,000 Series C Round”
Vivaldi BioSciences Obtains $23,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4d4eceb7-425c-4bbd-9378-7a81377215cf&Preview=1 Date 1/8/2009 Company Name Vivaldi BioSciences Mailing Address 750 Battery Street San Francisco, CA 94111 Company Description The company is developing influenza-targeted vaccines and therapeutics. Website Undisclosed Transaction Type Venture Equity Transaction Amount $23,000,000 Transaction Round Series A Proceeds Purposes Vivaldi intends to use the proceeds from the Series A financing … Continue reading “Vivaldi BioSciences Obtains $23,000,000 Series A Funding Round”
Gene Security Lands $6,000,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9e5cd925-0676-4bb0-abae-92b67bc83fa4&Preview=1 Date 1/8/2009 Company Name Gene Security Mailing Address 2686 Middlefield Road Redwood City, CA 94063 Company Description The mission of GSN is to help doctors give couples the best chance of having a healthy child. Our company was formed in 2004 by a team of doctors, geneticists, statisticians, and software engineers … Continue reading “Gene Security Lands $6,000,000 Series B Financing”
Rocket Lawyer Receives $2,090,000 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=709fd120-c943-47c0-9e60-c0ac51cb14ce&Preview=1 Date 1/8/2009 Company Name Rocket Lawyer Mailing Address 182 Howard St San Francisco, CA 94105 Company Description RocketLawyer.com is a service of Rocket Lawyer Incorporated. Our mission is to empower consumers, business professionals and lawyers to get and give legal help. Our comprehensive line of do it yourself legal assistance solutions … Continue reading “Rocket Lawyer Receives $2,090,000 Series B Funding Round”
OLPC Lays Off Half Its Staff—Refocusing Mission and Talking About the $0 Laptop
The One Laptop Per Child Foundation, the great dream of MIT Media Lab founder Nicholas Negroponte to bring low-cost, educational computing to children in the world’s developing nations and beyond, announced today a major layoff and refocusing of its mission. Only 32 staff will remain, about half the current number, according to Negroponte’s post on … Continue reading “OLPC Lays Off Half Its Staff—Refocusing Mission and Talking About the $0 Laptop”
EMC Cuts Put 2,400 Out of Work
EMC, the Hopkinton, MA-based data storage company that is one of the state’s largest tech employers, said today in an after-hours announcement that is cutting 2,400 people from its worldwide workforce. That’s a 7 percent reduction, based on the company’s size as of September 30. Though it expects to book record revenues of $4 billion … Continue reading “EMC Cuts Put 2,400 Out of Work”
OrthAlign Raises $7.2M
OrthAlign, a medical device company in Laguna Beach, CA, said today it has raised $7.2 million in a Series A financing. The round was led by Research Corporation Technologies and Okapi Venture Capital, and included some of the company’s seed investors, Ronald Yagoda, Ned Scheetz, and CEO Pieter Wolters. The company is developing computer-assisted surgical … Continue reading “OrthAlign Raises $7.2M”
Microsoft Gives Up New Seattle Lease
Microsoft has dropped out of negotiations to lease 300,000 square feet of Seattle office space at 2201 Westlake in South Lake Union, according to a report in the Seattle P-I. The report says a Microsoft spokesman cited the economy and market conditions as reasons for the move. In 2007, Microsoft leased a total of 166,000 … Continue reading “Microsoft Gives Up New Seattle Lease”
Neural Audio Acquired by DTS for $7.5M
Kirkland, WA-based Neural Audio, a digital sound company, has been acquired by DTS (NASDAQ: [[ticker:DTSI]]), a technology and entertainment firm in Agoura Hills, CA. The purchase price was $7.5 million in cash, with DTS also agreeing to pay up to $7.5 million more over the next five years if certain conditions are met. No other … Continue reading “Neural Audio Acquired by DTS for $7.5M”
Planar Sells Sign Business to CS Software
Beaverton, OR-based Planar Systems (NASDAQ: [[ticker:PLNR]]), a maker of monitors and displays, announced it has sold its remaining interest in its CoolSign Digital Signage business to CS Software Holdings. Terms of the deal were not disclosed. In November, Planar sold part of CoolSign to Bally Technologies, for gambling applications.
Kronos Cuts 250 Workers
Workforce management company Kronos is reducing its own workforce. The Chelmsford, MA-based company has laid off 250 people worldwide, including 100 in Chelmsford, according to a report today in Mass High Tech. That’s about 8 percent of the company’s overall staff. We’ve updated the Boston Tech Layoff Tracker with this new data.
ClickSquared, RatePoint Close Series B Rounds
Two local Internet-based marketing companies disclosed news of Series B funding rounds this week. ClickSquared, based in Needham, MA, said in a release yesterday that it has closed an $11 million Series B round led by JMI Equity, ABS Venture, and Flybridge Capital Partners. The company offers a software-as-a-service system that clients can use to … Continue reading “ClickSquared, RatePoint Close Series B Rounds”
Highland’s Blossomless Bet on Blue Tulip—Retailer Seeks Bankruptcy Protection
Highland Capital Partners is feeling the pinch of the reeling retail market. The Lexington, MA, venture fund has a 44-percent ownership stake in Blue Tulip, a New York-based chain of specialty gift shops that has filed for bankruptcy protection and plans liquidation sales at its 24 stores, according to a PE Hub report. Highland’s share … Continue reading “Highland’s Blossomless Bet on Blue Tulip—Retailer Seeks Bankruptcy Protection”
Accelrys CEO Resigns
Mark Emkjer has resigned as CEO and director at San Diego’s Accelrys (NASDAQ: [[ticker:ACCL]]), which develops software for computer-aided design and modeling. The company says its board has named Todd Johnson as interim CEO.
Omeros Nabs Michael J. Fox Grant
Omeros, a Seattle-based drug developer, said it has received a $465,000 grant from the Michael J. Fox Foundation for Parkinson’s Research. The grant will pay for research of a new target on brain cells discovered by Omeros scientists, which has been linked to movement disorders like Parkinson’s and Restless Leg Syndrome.
La Jolla Pharma Inks BioMarin Deal
La Jolla Pharmaceutical (NASDAQ: [[ticker:LJPC]]) has formed a partnership to co-develop its experimental drug for lupus of the kidneys, Riquent, with Novato, CA-based BioMarin Pharmaceuticals (NASDAQ: [[ticker:BMRN]]). La Jolla will receive a $15 million upfront payment, and could stand to get $289 million in cash and equity from BioMarin if the drug reaches certain development … Continue reading “La Jolla Pharma Inks BioMarin Deal”
Drug Manufacturing in Bioengineered Goats: FDA Says It Looks Safe
Would you take a drug made from the milk of a genetically modified goat? A committee of expert advisers to the FDA will take a swing at that question, weighing the safety and effectiveness of such a treatment on Friday. The U.S. drug regulator is seeking advice on whether to approve an application from Framingham, … Continue reading “Drug Manufacturing in Bioengineered Goats: FDA Says It Looks Safe”
San Diego’s Forward Ventures Moves Toward a Lean and Virtual Future
Speculation has been rampant in recent months about the future of San Diego’s Forward Ventures, which has been one of the region’s leading life sciences VC firms for more than 15 years. Partner Joel Martin, who joined Forward in 2001, left the firm in October and another partner, Stuart Collinson, is said to be leaving … Continue reading “San Diego’s Forward Ventures Moves Toward a Lean and Virtual Future”
Is Failure a Black Mark for Seattle Innovators? Insights from Erik Benson of Voyager Capital
Erik Benson is a quantum particle. OK, that’s the only metaphor I can think of to explain how he can be in so many places at once. The managing director of Voyager Capital is based in Seattle, but his orbit also includes Portland, OR, Silicon Valley, and San Diego. From what I can tell, he’s … Continue reading “Is Failure a Black Mark for Seattle Innovators? Insights from Erik Benson of Voyager Capital”
The Lowdown on Angel Capital from CommonAngels’ James Geshwiler
For startup entrepreneurs who need less than $5 million in capital, the venture capital industry might as well not exist. The average U.S. venture capital fund has doubled in size since 2000 to over $200 million, according to Dow Jones/VentureOne. That means most venture partners see investments of under $5 million as a waste of … Continue reading “The Lowdown on Angel Capital from CommonAngels’ James Geshwiler”
Supersized Ambitions: VentiRx Aims to be Extra-Large Player in Cancer, Allergy Medicines
They love their coffee at VentiRx. They love it so much that they named their San Diego- and Seattle-based biotech company after the extra-large size of beverage containers that Starbucks shrewdly branded for its menu. The name also happens to symbolize VentiRx’s supersize ambitions for creating new drugs against cancer and inflammatory diseases. Naturally, I … Continue reading “Supersized Ambitions: VentiRx Aims to be Extra-Large Player in Cancer, Allergy Medicines”
Forma Emerges With Well-Formed Cancer-Drug Strategy, Biogen Idec Preps for Parkinson’s Drug Data, Endo Buys out Indevus, & More Boston-Area Life Sciences News
We’ve got some M&A activity, some board-room drama, and some cool new companies and drug-development strategies–the year’s off to an interesting start for New England’s life sciences firms. —Forma Therapeutics, flush with $25 million from the likes of the Novartis Option Fund and Singapore’s Bio*One Capital, emerged from stealth mode to unveil its strategy for … Continue reading “Forma Emerges With Well-Formed Cancer-Drug Strategy, Biogen Idec Preps for Parkinson’s Drug Data, Endo Buys out Indevus, & More Boston-Area Life Sciences News”
RatePoint Lands $10,000,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea3f3eeb-1a34-4fd6-bcf1-1a61739687a5&Preview=1 Date 1/7/2009 Company Name RatePoint Mailing Address 100 Crescent Road Needham, MA 02494 Company Description With your active participation, we are: …creating the first personalized social rating service …providing you with valuable information that matches your likes and dislikes …helping you connect with like-minded people …allowing you to take control and … Continue reading “RatePoint Lands $10,000,000 Series B Financing”
ClickSquared Inc Obtains $11,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d6bc8043-dc12-4735-be7d-991ff1c70d1b&Preview=1 Date 1/7/2009 Company Name ClickSquared Inc Mailing Address 200 West Street 3rd Floor East Waltham, MA 02451 Company Description ClickSquared is the premier real time relationship marketing services provider of intelligent, multi-channel marketing solutions creating perfectly timed, personalized interactions across all online and off-line direct channels. Leveraging a team of marketing … Continue reading “ClickSquared Inc Obtains $11,000,000 Series B Financing Round”
Forma Therapeutics, Inc. Receives $25,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e2accd11-cb2d-4ed7-ad76-e41646743270&Preview=1 Date 1/7/2009 Company Name Forma Therapeutics, Inc. Mailing Address 50 Rowes Wharf, 3rd Floor Boston, MA 02110 Company Description The company develops therapeutic agents through the use of novel chemistry. Website Undisclosed Transaction Type Venture Equity Transaction Amount $25,000,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. M&A … Continue reading “Forma Therapeutics, Inc. Receives $25,000,000 Series A Financing”
Sentilla Corporation Obtains $7,500,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8a945268-04ef-406a-983b-9f27e6fea60a&Preview=1 Date 1/7/2009 Company Name Sentilla Corporation Mailing Address 201 Marshall St. Redwood City, CA 94063 Company Description Sentilla is about making the real world — and everything in it — smarter, with software for small computers that can be put anywhere or attached to anything. Called pervasive computing, this technology is … Continue reading “Sentilla Corporation Obtains $7,500,000 Series B Funding”
Intradigm Corporation Obtains $21,400,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9c944c3a-865d-4d98-ace2-a055777c5e03&Preview=1 Date 1/7/2009 Company Name Intradigm Corporation Mailing Address 3350 W Bayshore Rd Palo Alto, CA 94303 Company Description Our Mission: “To deliver the promise of RNA interference (RNAi) therapeutics for the treatment of human diseases with unmet medical needs through our advanced targeted systemic delivery technology with an initial focus on … Continue reading “Intradigm Corporation Obtains $21,400,000 Series B Financing Round”
Mobile Monday Boston
The next Mobile Monday Boston event, “Compelling Mobile Business Models,” will take place on Monday, January 12, at the Langham Hotel in Boston. Speakers from early, mid- and late-stage Boston-area mobile companies will discuss their organizations’ current business models, how those model have evolved over time, and the impact of the current economic climate. Free … Continue reading “Mobile Monday Boston”
How Blist Got Involved with Obama—the Inside Story
A Seattle startup is playing an important role in helping President-elect Barack Obama’s transition team get organized. As of yesterday, the Obama-Biden Transition Project has been using technology from Blist (pronounced as one syllable, and spelled with a lowercase “b” by its employees) to power its Change.gov website. The company’s software lets people create, manage, … Continue reading “How Blist Got Involved with Obama—the Inside Story”
Xconomy Forum: Physics for Future Presidents
An eye-opening discussion about energy, terrorism, and the future of technology that all citizens should hear Think you have a good read on the promise of clean energy and other core technological issues of the day? MacArthur “genius” award-winning physicist Richard A. Muller, one of the world’s most original thinkers on science and technology and … Continue reading “Xconomy Forum: Physics for Future Presidents”
WiMax Launches in Portland
Intel and Clearwire are announcing the launch of WiMax, a next-generation wireless broadband service, today in Portland, OR. It will provide high-speed Internet access to laptops and mobile devices across Portland, which is the second U.S. city to deploy the service (after Baltimore, MD). Last month, Clearwire received a $3.2 billion investment from Comcast, Intel, … Continue reading “WiMax Launches in Portland”
Adventrx Cuts Deeper
Adventrx, the San Diego-based cancer drug developer, said it has laid off another group of employees, meaning it has cut 55 percent of its workforce since the beginning of October. The company now has 14 employees left. The company had $15 million in cash at the end of September, and a net loss of $6.7 … Continue reading “Adventrx Cuts Deeper”
Molecular Insight Pharma Director Barlow Resigns Over Rift with Board
The former CEO and chairman of Molecular Insight Pharmaceuticals (NASDAQ:[[ticker:MIPI]]), David Barlow, resigned from the firm’s board of directors last week over differences with fellow directors, according to a press release from the Cambridge, MA-based company. The exact nature of those differences is unclear, but Barlow alluded to “significant and sustained disagreements…regarding business philosophy, strategy … Continue reading “Molecular Insight Pharma Director Barlow Resigns Over Rift with Board”
Premise Sold to Eclipsys
Healthcare software firm Eclipsys reports it has completed its buyout of Farmington, CT-based Premise, a provider of patient-tracking software for hospitals. Last week Atlanta-based Eclipsys (NASDAQ:[[ticker:ECLP]]) said it would pay $38.5 million in cash to acquire venture-backed Premise.
BSX Buys Irish Stent Firm
Boston Scientific (NYSE:[[ticker:BSX]]), the Natick, MA-based medical devices giant, reports that it has acquired drug-eluting stent developer Labcoat, headquartered in Galway, Ireland. Labcoat has developed technology to produce ultra-thin coatings of biodegradable polymers and drugs on the outer surface of coronary stents, which are designed to prop open arteries after surgeries to remove plaques. Financial … Continue reading “BSX Buys Irish Stent Firm”
Proclaiming the iPod is Dying, MP3.com’s Founder Launches A Web Site for Downloading Music to Your Cell Phone
San Diego’s MP3.com founder Michael Robertson says the iPod is dying and in a few years, “it will be just a footnote in history.” Robertson recently predicted the passing of the enormously successful Apple music player in a provocative blog entry that argues mobile phones are destined to become the next-generation music player. He also … Continue reading “Proclaiming the iPod is Dying, MP3.com’s Founder Launches A Web Site for Downloading Music to Your Cell Phone”
Broad Institute Scientists’ Forma Therapeutics Raises $25M, Aims to Knock Out Underpinnings of Cancer
Forma Therapeutics, a startup company co-founded by scientists at the Broad Institute of Harvard and MIT, has raised $25 million to create drugs that build on research that has yielded clues about the root genetic causes of what makes a cell turn cancerous. Forma, based in Cambridge, MA, was formed 2007 to generate drug compounds … Continue reading “Broad Institute Scientists’ Forma Therapeutics Raises $25M, Aims to Knock Out Underpinnings of Cancer”
EMC Buys SourceLabs, Qwell Raises $7M, Microsoft Layoff Rumors Rebuffed (For Now), & More Seattle-Area Deals News
It’s been a pretty slow couple of weeks for deals in the Northwest, what with the holidays. But there were still some big ones in software and biotech—starting with an Xconomy exclusive below. —Xconomy broke the news this morning that Seattle-based Qwell Pharmaceuticals has raised a $7 million Series A round led by Arch Venture … Continue reading “EMC Buys SourceLabs, Qwell Raises $7M, Microsoft Layoff Rumors Rebuffed (For Now), & More Seattle-Area Deals News”
Cleantech Engine Revved In ’08—Deals to Remember
These are the salad days for the Boston area’s developers of alternative energy and clean technologies. Such firms had no problem landing big deals with corporate partners, governments, and investors in 2008. At the risk of sounding whimsical, the standout cleantech deals in 2008 provoked thoughts of a not-so-distant future when, for example, advanced batteries … Continue reading “Cleantech Engine Revved In ’08—Deals to Remember”
Qwell Pharmaceuticals, Backed by Arch, Raises $7M for New Cancer, Inflammation Drugs
Xconomy has learned that Qwell Pharmaceuticals, a Seattle-based drug developer in stealth mode, has raised $7 million in a Series A financing. The investment was led by Arch Venture Partners and the Wellcome Trust, the world’s second-biggest charitable foundation for biomedical research. Qwell’s goal is to develop a new family of small-molecule drugs, derived from … Continue reading “Qwell Pharmaceuticals, Backed by Arch, Raises $7M for New Cancer, Inflammation Drugs”